Eric di Luccio is Executive Director, Chief Technology Officer, and Head of R&D and Intellectual Property at HIROTSU BIO SCIENCE, in Japan, since 2020. Before his industry career, he served as Associate Professor (2014–2020) and Assistant Professor (2010–2014) at Kyungpook National University in South Korea, focusing his research on epigenetic anticancer therapeutics, and began his research career as a post-doctoral researcher and lecturer in Molecular and Cellular Biology and Bioinformatics at the University of California, Davis (2003–2009). Holding a PhD in Neuroscience, he has led research groups across academia and industry in cancer therapeutics and cancer diagnosis for more than 15 years.
Hirotsu Bio Science Inc.
Tokyo, Japan
Research Director
HIROTSU BIO SCIENCE
01 Oct 2022 - present
Institute, Department or Faculty Head
HIROTSU BIO SCIENCE
01 Sep 2020 - present
Senior Scientist or Principal Investigator
Kyungpook National University
01 Jan 2010 - 01 Aug 2020
Post Doctoral Researcher
University of California, Davis
01 Nov 2003 - 01 Dec 2009
Graduate Student or Post Graduate
University of the Mediterranean / CNRS (Centre National de la Recherche Scientifique) France
01 Sep 1999 - 01 Oct 2003